An intervention trial to reduce venous cannulation associated thrombophlebitis

Reduction of Incidence of venous cannulation associated thrombophlebitis among patients admitted in wards in PDHNH A randomized clinical trial of five different interventions - NA

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/03/082857

Enrollment

1230

Registered

2025-03-19

Start date

Unknown

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: R229- Localized swelling, mass and lump,unspecified

Interventions

Intervention1: Group A Frequency of checking outcome is every 8 hours The intervention will be carried out for 10 months: On a daily basis the assigned nurse in the ward will assess your peripheral ca

Eligibility

Inclusion criteria

Inclusion criteria: 1 Patients having peripheral venous cannulation access for treatment therapy 2 patient admitted and staying for more than 24 hours

Exclusion criteria

Exclusion criteria: Patients below 18 years of age Patient availing services in OPD A & E Day care and OT facility Patient admitted in any location other than the study wards Patient having peripheral line at the time of admission

Design outcomes

Primary

Measure	Time frame
Reduce the incidence of thrombophlebitisTimepoint: every 8 hours until removal of cannula	—

Secondary

Measure	Time frame
severity of thrombophlebitisTimepoint: every 8 hours until removal of cannula	—

Countries

India

Contacts

Public ContactDr Meenu Jain

P D Hinduja Hospital and Medical Research Centre

meenurishijain@gmail.com9833580037

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Sep 19, 2026